Tenofovir Disoproxil, Emtricitabine/Tenofovir Disoproxil and Entecavir

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000494525-2017-09-06T00:00:00Z",
    "date": "2017-09-06T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000494525",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-1",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Stephanie McNiven",
                "email": "stephaniemcniven@nhs.net",
                "telephone": "+44 1698794410",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-30",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "loraine.hartley@nhs.net",
                "telephone": "+44 1312756366",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-30"
    },
    "tender": {
        "id": "NP47117",
        "title": "Tenofovir Disoproxil, Emtricitabine/Tenofovir Disoproxil and Entecavir",
        "description": "Supply of Tenofovir Disoproxil Tablets and Granules, Emtricitabine/Tenofovir Disoproxil Tablets and Entecavir Tablets to NHS Scotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "3"
            }
        ],
        "value": {
            "amount": 20510000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk",
        "tenderPeriod": {
            "endDate": "2017-06-26T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2017-06-26T12:00:00Z"
        },
        "documents": [
            {
                "id": "MAY283896",
                "documentType": "contractNotice",
                "title": "Tenofovir Disoproxil, Emtricitabine/Tenofovir Disoproxil and Entecavir",
                "description": "Supply of Tenofovir Disoproxil Tablets and Granules, Emtricitabine/Tenofovir Disoproxil Tablets and Entecavir Tablets and Oral Solution to NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY283896",
                "format": "text/html"
            },
            {
                "id": "SEP294859",
                "documentType": "awardNotice",
                "title": "Tenofovir Disoproxil, Emtricitabine/Tenofovir Disoproxil and Entecavir",
                "description": "Supply of Tenofovir Disoproxil Tablets and Granules, Emtricitabine/Tenofovir Disoproxil Tablets and Entecavir Tablets to NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP294859",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "title": "Tenofovir Disoproxil",
                "description": "This Lot is for the supply of tenofovir disoproxil tablets and granules to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. Each product line has been treated as an individual Lot and awarded on a line by line basis to a single supplier.",
                "status": "complete",
                "value": {
                    "amount": 2760000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 540
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                }
            },
            {
                "id": "2",
                "title": "Emtricitabine/Tenofovir Disoproxil",
                "description": "This framework agreement is for the supply of Tenofovir Disoproxil/Emtricitabine tablets to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. This Lot has been awarded as a ranked multi supplier framework to five (5) suppliers.",
                "status": "complete",
                "value": {
                    "amount": 17400000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 540
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                }
            },
            {
                "id": "3",
                "title": "Entecavir",
                "description": "This framework agreement is for the supply of Entecavir tablets to NHS Scotland. This will require supply of medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. Each product line has been treated as an individual Lot and awarded on a line by line basis to a single supplier.",
                "status": "complete",
                "value": {
                    "amount": 350000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 540
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                }
            }
        ],
        "lotDetails": {
            "maximumLotsBidPerSupplier": 2147483647
        },
        "bidOpening": {
            "date": "2017-06-26T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situations referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines prior to the commencement of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All Goods must comply with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
                    "minimum": "(a) Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines will be in place prior to the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under Technical and Professional Ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional Ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional Ability: Products."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 5
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false
    },
    "language": "EN",
    "description": "The estimated values referred to in Sections II.I.7 and each Lot covers the initial eighteen (18) month duration and the two (2) twelve (12) month extension periods of the framework agreement. (SC Ref:507628)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000494525"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000494525"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP47117-1",
            "title": "Tenofovir Disoproxil",
            "relatedLots": [
                "1"
            ]
        },
        {
            "id": "NP47117-2",
            "title": "Emtricitabine/Tenofovir Disoproxil",
            "relatedLots": [
                "2"
            ]
        },
        {
            "id": "NP47117-3",
            "title": "Entecavir",
            "relatedLots": [
                "3"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP47117-1",
            "awardID": "NP47117-1",
            "title": "Tenofovir Disoproxil",
            "status": "active",
            "dateSigned": "2017-08-08T00:00:00Z"
        },
        {
            "id": "NP47117-2",
            "awardID": "NP47117-2",
            "title": "Emtricitabine/Tenofovir Disoproxil",
            "status": "active",
            "dateSigned": "2017-08-08T00:00:00Z"
        },
        {
            "id": "NP47117-3",
            "awardID": "NP47117-3",
            "title": "Entecavir",
            "status": "active",
            "dateSigned": "2017-08-08T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2017/S 099-195718"
        }
    ]
}